Pierre Dahdah1, Giuseppe Bruschi2* and Victor Jebara1
1Department of Thoracic & Cardiovascular Surgery, “Hotel-Dieu de France” Hospital, Beirut, Lebanon
2“De Gasperis” Cardiac Center, ASST Niguarda General Hospital, Italy
Received: 12 August, 2016; Accepted: 27 September, 2016; Published: 28 September, 2016
Giuseppe Bruschi, “De Gasperis” Cardiac Center, ASST Niguarda General Hospital, Piazza dell’Ospedale Maggiore 3, 20162 Milan, Italy, Tel: +39.02.6444.2565; E-mail:
Dahdah P, Bruschi G, Jebara V (2016) Direct Aortic Evolut R Implantation as Valve-In-Valve in a Patient Affected by Leriche Syndrome. J Cardiovasc Med Cardiol 3(1): 038-040. DOI: 10.17352/2455-2976.000030
© 2016 Dahdah P,et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Transcatheter valve implantation; Surgery; Aortic; Aortic valve disease
Transcatheter aortic valve implantation (TAVI) has been designed to treat elderly patients with severe aortic stenosis considered high-risk surgical candidates.
Due to the large device size, even of current generation systems, the trans-femoral approach requires favorable ilio-femoral arterial anatomy; this approach is contraindicated in patients with excessive atherosclerosis, calcifications, or tortuosity of ilio-femoral arteries.
We report the case of a 75-year-old female affected by Leriche syndrome who successfully underwent direct aortic (DAo) transcatheter aortic valve implantation with a Medtronic CoreValve Evolut R (Medtronic Inc., Minneapolis, MN, USA) as valve-in-valve implantation to treat a degenerate aortic bioprosthesis.
Transcatheter aortic valve implantation (TAVI) is an appropriate therapy to treat elderly patients with severe aortic stenosis considered high-risk surgical candidates. The safety and effectiveness of TAVI have been demonstrated in numerous observational clinical studies, national registries and also in controlled randomized trial [1,2].
The less invasive approach should be considered the trans-femoral one, nevertheless a number of patients that are referred for TAVI are not eligible for trans-femoral access due to calcification, vascular narrowing, or tortuosity of ileo-femoral arteries. For them, the transapical, subclavian, or direct aortic approaches may be a suitable alternative. The choice of alternative access should be determined by the heart team based on anatomic characteristics and clinical status of the patient.
We report the case of a 75-year-old female affected by Leriche syndrome who successfully underwent valve-in-surgical valve TAVI, through a direct aortic approach, with a Medtronic CoreValve Evolut R.
The Evolut R maintains the cell geometry of the prior CoreValve prosthesis to optimize frame conformance to the native aortic annulus, the delivery system is designed to have a stable and predictable deployment with the advantage, if necessary, to re-sheath, reposition, and redeploy the valve. Evolut R system used the new, catheter-mounted InLine sheath, which eliminates the need for an external sheath; this sheath has a lower equivalent to the outer diameter of a 14-F sheat .
A 75 year-old female was admitted, on January 2016, for congestive heart failure at our hospital. The patient had undergone in 2011 aortic valve replacement with a biological Carpentier-Edwards Magna 23 mm prosthesis (Edwards Lifesciences, Irvine, CA). She was also affected by severe chronic renal failure (creatinine clearance 30 ml/min), oxygen dependent chronic obstructive pulmonary disease (COPD) and epi-aortic vessels vasculopathy with left subclavian artery occlusion and 70% stenosis of left internal carotid artery. The patient suffered from aorto-iliac occlusive disease with complete occlusion of the aorta distal to the renal arteries. To treat Leriche syndrome in 2014 she underwent axillo-bi-femoral bypass with extra-anatomic technique (Figure 1A), at that time transthoracic echocardiography (TTE) revealed normal left ventricle (LV) function with mean gradient of the aortic bioprosthesis of 15 mmHg. Six month after surgery the patient experienced shortness of breath with NYHA Class III; ambulatory TTE showed an increased gradient through the aortic bioprosthesis with a mean gradient of 50 mmHg. Valve thrombosis was suspected and Coumadin was prescribed. Her condition continued to deteriorate in spite of an INR between 2.5 and 3.0. During this period, she was readmitted three times for bouts of congestive heart failure. All blood essays for systemic inflammatory diseases were negative.
- Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, et al. (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370: 1790-1798 .
- Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, et al. (2016) Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 374: 1609-1620.
- Sinning JM, Werner N, Nickenig G, Grube E (2013) Medtronic CoreValve Evolut R with EnVeo R. EuroIntervention 9: S95-S96.
- Sénage T, Le Tourneau T, Foucher Y, Pattier S, Cueff C, et al. (2014) Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients. Circulation 130: 2012-2020 .
- Dohi M, Doi K, Yaku H (2015) Early stenosis of an aortic porcine bioprosthesis due to thrombosis: Case report and literature review. J Thorac Cardiovasc Surg 149: e83-e86 .
- Cremer PC, Rodriguez LL, Griffin BP, Tan CD, Rodriguez ER, et al. (2015) Early Bioprosthetic Valve Failure: Mechanistic Insights via Correlation between Echocardiographic and Operative Findings. J Am Soc Echocardiogr 28: 1131-1148 .
- Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, et al. (1993) A comparison of outcomes in men 11 years after heart- valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. N Engl J Med 328: 1289-1296 .
- Dvir D, Webb JG, Bleiziffer S, Pasic M, Waksman R, et al. (2014) Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA 312: 162-170 .
- Bruschi G, De Marco F, Botta L, Barosi A, Colombo P, Eet al. (2015) Right anterior mini-thoracotomy direct aortic self-expanding trans-catheter aortic valve implantation: A single center experience. Int J Card 181: 437–442 .
- Hayashida K, Romano M, Lefèvre T, Chevalier B, Farge A, et al (2013) The transaortic approach for transcatheter aortic valve implantation: a valid alternative to the transapical access in patients with no peripheral vascular option. A single center experience. Eur J Cardiothorac Surg 44: 692-700 .
- Bruschi G, De Marco F, Botta L, Oreglia J, Colombo P, et al. (2012) Direct transaortic CoreValve implantation through right mini-thoracotomy in patients with patent coronary grafts. Ann Thorac Surg 93: 1297–1299 .